[144] Penumbra, Inc. SEC Filing
Penumbra, Inc. (PEN) Form 144 notice: An affiliated person proposes to sell 15,800 shares of common stock through Morgan Stanley Smith Barney on 09/03/2025. The shares were acquired the same day by stock option exercise and paid in cash. The filing reports an aggregate market value of $4,260,403.64 for the proposed sale and lists 38,999,129 shares outstanding for the issuer. The notice also discloses six prior open-market sales by the same person between 06/11/2025 and 08/20/2025, totaling 95,865 shares sold in the past three months, with separate gross proceeds reported for each trade. The filer attests there is no undisclosed material adverse information.
- Complete disclosure of broker, acquisition method (stock option exercise), sale date, and aggregate market value
- Itemized prior sales in the past three months provide transparent historical trading activity by the seller
- Multiple recent insider sales totaling 95,865 shares in the past three months, which may attract investor attention even though quantity is small relative to shares outstanding
- No 10b5-1 plan date provided in the form, so the filing does not indicate a prior written trading plan
Insights
TL;DR: Routine insider exercise and planned sale, with multiple recent dispositions but small relative to total shares outstanding.
The filing records an insider stock option exercise followed by a proposed sale of 15,800 shares on 09/03/2025, executed through Morgan Stanley Smith Barney. The filing transparently discloses past transactions: six open-market sales totaling 95,865 shares across June–August 2025. Relative to the issuer's reported 38,999,129 shares outstanding, the cumulative recent sales represent a small fraction of outstanding equity, indicating limited direct dilution or immediate market-impact risk. This is a standard Rule 144 disclosure and does not include operational or financial results.
TL;DR: Compliance-focused disclosure showing adherence to Rule 144 procedures; no governance red flags in the notice itself.
The document furnishes required seller identity, broker details, acquisition date and nature (stock option exercise), and confirmation of absence of undisclosed material information. The repeated sales over the prior three months are fully itemized with dates and gross proceeds, which supports transparency. The filing contains no claims about trading plans or 10b5-1 adoption dates; absence of such a plan is explicitly noted by lack of a plan date in the form fields.